In
this study, an active pharmaceutical ingredient, primidone,
was recrystallized through supercritical antisolvent precipitation
(SAS) by using CO2 as the antisolvent. The operating parameters
of SAS, such as the solvent system, operating temperature and pressure,
solution concentration and flow rate, CO2 flow rate, and
nozzle diameter, were studied systematically. The solid-state properties
of the original and processed primidone, including crystal habit,
mean particle size, polymorphic form, and residual solvent content,
were analyzed and are discussed. Two novel polymorphic forms of primidone,
forms C and D, were obtained, and their crystal habits and mean particle
sizes before and after SAS differed significantly. In addition, the
dissolution profiles of the original and processed primidone were
studied and compared. The experimental results showed that the recrystallized
primidone had an enhanced dissolution rate compared with the original
primidone. These results demonstrate that through SAS the solid-state
properties of primidone can be controlled and modified and that microparticles
with a novel polymorphic form and enhanced dissolution behavior can
be produced.